Shikoku Cancer Center - Academic Profile

Publications

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Mark A. Socinski , Robert M. Jotte , Federico Cappuzzo +17 more

The addition of atezolizumab to bevacizumab plus chemotherapy significantly improved progression-free survival and overall survival among patients with metastatic nonsquamous NS...

2018 New England Journal of Medicine 3592 citations

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Masahiro Fukuoka , Seiji Yano , Giuseppe Giaccone +17 more

Purpose: To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839]; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine ki...

2003 Journal of Clinical Oncology 2877 citations

Affiliated Researchers

Naoyuki Nogami

Shikoku Cancer Center

Institution Info

Type: healthcare
Country: JP
Publications: 2
Citations: 6,469

External Links

Identifiers

ROR: https://ror.org/03yk8xt33